
Sen-Jam Pharmaceutical
Revolutionizing Inflammatory Care So Humanity Can Thrive
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredOct 30, 2015 (11 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- JIJim Iversen Co-Founder/CEOsource: sen-jam.com
- JIJacqueline Iversen Co-Founder, Chief Clinical Officersource: sen-jam.com
Similar Health and bio companies
VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
PPhrontline Biopharma$40M Series A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sen-jam-pharmaceutical (get a free API key).